Acrivon Therapeutics presents data on ACR-2316's tumor cell death mechanisms and early clinical trial results at AACR 2025. Acrivon Therapeutics has announced that it will present findings on ACR-2316 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results